Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
ATAD5 protein, partial | 3 | 0 | 0 | 3 |
GLS protein | 2 | 0 | 0 | 2 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
Smad3 | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
progesterone receptor | 4 | 0 | 0 | 4 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
estrogen-related nuclear receptor alpha | 5 | 0 | 0 | 5 |
estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 8 | 0 | 8 |
Multidrug resistance-associated protein 4 | 0 | 8 | 0 | 9 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 3 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Bile salt export pump | 0 | 11 | 0 | 11 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 3 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 5 | 0 | 6 |
Cytochrome P450 2C9 | 0 | 2 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 2 | 0 | 3 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 4 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 3 | 0 | 3 |
GABA theta subunit | 1 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 8 | 0 | 8 |
Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
toxin B | 0 | 0 | 0 | 1 |
TDP1 protein | 6 | 0 | 0 | 6 |
AR protein | 5 | 0 | 0 | 5 |
glucocorticoid receptor [Homo sapiens] | 7 | 0 | 0 | 7 |
Cellular tumor antigen p53 | 5 | 0 | 0 | 5 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostacyclin receptor | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
G | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
IDH1 | 3 | 0 | 0 | 3 |
NEDD8-activating enzyme E1 regulatory subunit isoform a | 0 | 1 | 0 | 1 |
NEDD8-conjugating enzyme Ubc12 | 0 | 1 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
geminin | 4 | 0 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Interferon beta | 3 | 0 | 0 | 3 |
HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 6 | 0 | 6 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 2 | 0 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
Chain H, Proteasome component PUP1 | 0 | 1 | 0 | 1 |
Chain I, Proteasome component PUP3 | 0 | 1 | 0 | 1 |
Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-11 | 0 | 1 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
polyprotein | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 4 | 0 | 0 | 4 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
caspase-3 | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
Histone H2A.x | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 4 | 0 | 0 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
26S proteasome non-ATPase regulatory subunit 11 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 12 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 14 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-7 | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 3 | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Cathepsin B | 0 | 1 | 0 | 1 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Cathepsin G | 0 | 2 | 0 | 2 |
Lysosomal protective protein | 0 | 1 | 0 | 1 |
Chymotrypsinogen B | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 6A | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-1 | 0 | 1 | 0 | 2 |
Chymase | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-1 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 2 | 0 | 3 |
26S proteasome regulatory subunit 7 | 0 | 1 | 0 | 1 |
Lon protease homolog, mitochondrial | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-10 | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 6B | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 8 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-3 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 1 | 0 | 2 |
26S proteasome non-ATPase regulatory subunit 7 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 4 | 0 | 1 | 0 | 1 |
26S proteasome complex subunit SEM1 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 4 | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 8 | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 10B | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
Transcription factor p65 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 2 | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 6 | 0 | 1 | 0 | 1 |
Proteasomal ubiquitin receptor ADRM1 | 0 | 1 | 0 | 1 |
ATP-dependent Clp protease proteolytic subunit | 0 | 1 | 1 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha-type 8 | 0 | 1 | 0 | 1 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Proteasome subunit beta type-7 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 1 | 0 | 1 | 0 | 1 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 13 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 3 | 0 | 4 |
Kappa-type opioid receptor | 0 | 3 | 1 | 7 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
67.9K protein | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
Histamine H1 receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Transthyretin | 0 | 0 | 1 | 3 |
Albumin | 0 | 1 | 1 | 2 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
thioredoxin reductase | 2 | 0 | 0 | 2 |
GALC protein | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 2 | 0 | 0 | 2 |
arylsulfatase A | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 4 | 0 | 0 | 4 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Estrogen receptor | 0 | 2 | 2 | 6 |
Estrogen receptor | 0 | 1 | 1 | 2 |
Progesterone receptor | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 2 | 0 | 2 |
Beta-lactamase TEM | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Bile acid receptor | 0 | 1 | 0 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Luciferase | 2 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 1 | 2 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 1 | 2 |
Albumin | 0 | 0 | 1 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
Chain A, Isoleucyl-tRNA synthetase | 0 | 1 | 0 | 1 |
heat shock protein 90 | 0 | 0 | 1 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
Isoleucine--tRNA ligase | 0 | 1 | 0 | 1 |
L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
Delta-type opioid receptor | 0 | 2 | 1 | 4 |
Delta-type opioid receptor | 0 | 2 | 1 | 3 |
Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
Mu-type opioid receptor | 0 | 2 | 1 | 3 |
Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
Mu-type opioid receptor | 0 | 2 | 2 | 6 |
Delta-type opioid receptor | 0 | 2 | 2 | 6 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 1 | 4 |
Mu-type opioid receptor | 0 | 2 | 1 | 4 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Oxytocin receptor | 0 | 2 | 2 | 4 |
Vasopressin V1a receptor | 0 | 1 | 0 | 1 |
Vasopressin V1a receptor | 0 | 2 | 1 | 3 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |